Feasibility of Use of a Mobile Application for Smoking Cessation in a Primary Care Population

Abstract Background: To expedite the use of evidence-based smoking cessation interventions (EBSCIs) in primary care and to thereby increase the number of successful quit attempts, a referral aid was developed. This aid aims to optimize the referral to and use of EBSCIs in primary care and to increase adherence to Dutch guidelines for smoking cessation. Methods: Practice nurses (PNs) will be randomly allocated to an experimental condition or control condition, and will then recruit smoking patients who show a willingness to quit smoking within six months. PNs allocated to the experimental condition will provide smoking cessation guidance in accordance with the referral aid. Patients from both conditions will receive questionnaires at baseline and after six months. Cessation effectiveness will be tested via multilevel logistic regression analyses. Multiple imputations as well as intention to treat analysis will be performed. Intervention appreciation and level of informed decision-making will be compared using analysis of (co)variance. Predictors for appreciation and informed decision-making will be assessed using multiple linear regression analysis and/or structural equation modeling. Finally, a cost-effectiveness study will be conducted. Discussion: This paper describes the study design for the development and evaluation of an information and decision tool to support PNs in their guidance of smoking patients and their referral to EBSCIs. The study aims to provide insight into the (cost) effectiveness of an intervention aimed at expediting the use of EBSCIs in primary care.

Download Full-text

Behavioral and biologic evidence of persistent high-risk behavior in an HIV primary care population

AIDS ◽

10.1097/00002030-200002180-00012 ◽

2000 ◽

Vol 14 (3) ◽

pp. 297-301 ◽

Cited By ~ 49

Author(s):

Emily J. Erbelding ◽

David Stanton ◽

Thomas C. Quinn ◽

Anne Rompalo

Keyword(s):

Primary Care ◽

High Risk ◽

Risk Behavior ◽

High Risk Behavior ◽

Primary Care Population ◽

Hiv Primary Care

Download Full-text

Cross-Cultural Comparisons of Subjective Cognitive Complaints in a Diverse Primary Care Population

Journal of Alzheimer s Disease ◽

10.3233/jad-201399 ◽

2021 ◽

pp. 1-11

Author(s):

Danelly Rodríguez ◽

Emmeline Ayers ◽

Erica F. Weiss ◽

Joe Verghese

Keyword(s):

Primary Care ◽

Depressive Symptoms ◽

Cognitive Function ◽

African Americans ◽

Primary Care Clinic ◽

Depression Scale ◽

Cognitive Complaints ◽

Care Clinic ◽

Primary Care Population ◽

Subjective Cognitive Complaints

Background: Very few studies have explored the utility of subjective cognitive complaints (SCCs) in primary care settings. Objective: We aim to investigate associations between SCCs (item-level), objective cognitive function (across domains and global), and mood in a diverse primary care population, including subjects with mild cognitive impairment. Methods: We studied 199 (75.9%females; 57.8%Hispanics; 42.2%African Americans) older adults (mean age 72.5 years) with memory concerns at a primary care clinic. A five-item SCC questionnaire, and objective cognitive assessments, including the Montreal Cognitive Assessment (MoCA) and the Geriatric Depression Scale, were administered. Results: Logistic regression analyses showed associations between SCC score and depressive symptoms. A memory-specific (“memory worsening”) SCC predicted scores on the MoCA (p = 0.005) in Hispanics. Conclusion: SCCs are strongly linked to depressive symptoms in African Americans and Hispanics in a primary care setting; a specific type of SCC is related to global cognitive function in Hispanics.

Download Full-text

OP17 Examining inequality in trials of smoking cessation interventions delivered in primary care: critique and reanalysis of cochrane reviews

10.1136/jech-2020-ssmabstracts.17 ◽

2020 ◽

Author(s):

JM Birch ◽

H Dambha-Miller ◽

SJ Griffin ◽

GB Hutton ◽

MP Kelly ◽

...

Keyword(s):

Primary Care ◽

Smoking Cessation ◽

Cochrane Reviews

Download Full-text

Triptan use after starting prophylactic migraine treatment: A retrospective cohort study in a primary care population

Cephalalgia ◽

10.1177/0333102414521511 ◽

2014 ◽

Vol 34 (11) ◽

pp. 927-932 ◽

Cited By ~ 2

Author(s):

Antonia FH Smelt ◽

Willem JJ Assendelft ◽

Christel E van Dijk ◽

Jeanet W Blom

Keyword(s):

Primary Care ◽

Clinical Trials ◽

Cohort Study ◽

Retrospective Cohort ◽

Daily Practice ◽

Rank Test ◽

Migraine Treatment ◽

Prophylactic Effect ◽

Primary Care Population ◽

Wilcoxon Rank Test

Background Clinical trials on the prophylactic effect of propranolol and metoprolol for migraine show that starting this medication leads to a decrease in the use of attack medication of 0.9–8.9 doses per month. However, studies in daily practice are lacking. Methods We compared the number of triptans prescribed in the six months before and the six months after the start of propranolol/metoprolol in a Dutch national representative primary care cohort. Results Of the 168 triptan-using patients who started with propranolol or metoprolol, the number of triptans prescribed before starting was 4.6 doses per month. The number of triptans prescribed six months before compared with six months after starting propranolol/metoprolol decreased with 1.0 dose per month (Wilcoxon rank test; p = 0.000). Conclusion In this primary care population, although the number of triptans prescribed decreased after starting propranolol or metoprolol, the decrease is relatively small compared to data from clinical trials.

Download Full-text